✦ LIBER ✦

Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban

✍ Scribed by Morell, Jason; Sullivan, Bridgette; Khalabuda, Marina; McBride, Brian F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban and other non-vitamin K anta

✍ Patrick Goldstein, Ismaïl Elalamy… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 213 KB

Prevention and treatment of experimental

✍ Biemond, Bart J.; Perzborn, Elisabeth; Friederich, Philip W.; Levi, Marcel; Buet 📂 Article 📅 2007 🏛 Schattauer 🌐 English ⚖ 899 KB

The potential role of new oral anticoagu

✍ Thomas Mavrakanas; Henri Bounameaux 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Dose-escalation study of rivaroxaban (BA

✍ Bengt I. Eriksson; Lars C. Borris; Ola E. Dahl; Sylvia Haas; Menno V. Huisman; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 302 KB

The role of interleukin-1 receptor antag

✍ W. P. Arend 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 178 KB

Potential role of oral anticoagulants in

✍ Doraiswamy, Vijay A; Slepian, Marvin J; Gesheff, Martin G; Tantry, Udaya S; Gurb 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 431 KB